| 

PTA gains fade as downstream buyers push back on higher costs

The PTA prices are stable from last two days, market showed a clear week-on-week recovery between April * and April ** across all major regions, indicating a short-term bullish phase after an earlier dip. Prices rebounded consistently, with the Council on Foreign Relations (CFR) China rising by about *.* per cent (from *.*** to *.***) and Free On-Board Korea (FOB) Korea showing a similar increase of around *.* per cent (from *.*** to *.***), reflecting stronger momentum in northeast Asia driven by firmer feedstock costs and improved sentiment. Meanwhile, CFR southeast Asia increased by about *.* per cent (from *.*** to *.***) and Cost, Insurance, and Freight (CIF) India rose by around *.* per cent (from *.*** to *.***), indicating a relatively moderate but steady recovery in these regions. On a year-on-year basis, PTA prices are higher by approximately +**.* per cent in CFR China, +**.* per cent in CFR southeast Asia, +**.* per cent in CIF India, and +**.* per cent in FOB Korea, highlighting a strong recovery compared to **** levels.

PTA prices entered a period of quiet consolidation through the second half of March, holding in a narrow band of $*.**–$*.**/kg for paraxylene, with PTA closely shadowing feedstock moves. The market was in a classic wait-and-watch mode, buyers deferred purchases anticipating a more attractive entry, while sellers resisted further concessions. PTA inventories were elevated, with average stock levels exceeding ** days, capping any meaningful upside and keeping the market psychologically heavy. Monoethylene Glycol (MEG) supply dynamics added a nuanced layer: Saudi Basic Industries Corporation (SABIC) redirected MEG volumes to India from its Yanbu complex, trimming allocations to Europe and China, a structural shift that slightly relieved India&#**;s MEG tightness without triggering price fireworks.